According to Medical News Today, a new study had been done regarding growths in the brain with mice. These creatures have been utilized in brain tumor research efforts before, of course, and some of the finest results have come to the surface. When there are efforts seen amongst these mice, it is very likely that humans will be able to benefit from them in some way or another. I believe this to be the case after reading up on the results that came from this particular study.
The article talked about how those within the John Hopkins University School of Medicine have been able to bring this drug into great effect. For those of you not in the know, 5-azacytidine may be able to prove useful in the realm of brain tumor research. You have to keep in mind that it had a previous effect on pre-leukemia in the past. It has since been utilized in this study, which should be focused on by organizations such as Voices against Brain Cancer.
Gliomas - seen as the most common and rapidly growing tumors in the brain - are going to be helped thanks to this drug. In particular, the drug will be able to target the mutation referred to simply as IDH1. For those of you who are unfamiliar with what exactly this entails, it is an alteration that is seen in 70 to 80 percent of all lower-grade tumors in patient. This mutation will make it impossible for the body to utilize protein for the sake of transitioning glucose into energy.
The study went on for a period of 14 weeks and the impact of 5-azacytidine had proven itself to be, to say the least, beneficial. Tumor growth in mice went down tremendously and a relapse did not occur since that point. It didn't even stop seven weeks after the use of the drug in question had been stopped. I do not think that you need me to tell you that this is extremely beneficial for those who have seen difficulties in terms of therapies and tumor regression.
Researchers typically do not expect to see tumor regression, which speaks volumes about how strong this study was in the realm of brain tumor research. These findings could prove useful in the future if the mice utilized have seen positive results. Is it possible that humans will be able to benefit from such processes in the long term as well? I like to think that this will be the case but it is just a matter of time as potential work will be gone about.
The article talked about how those within the John Hopkins University School of Medicine have been able to bring this drug into great effect. For those of you not in the know, 5-azacytidine may be able to prove useful in the realm of brain tumor research. You have to keep in mind that it had a previous effect on pre-leukemia in the past. It has since been utilized in this study, which should be focused on by organizations such as Voices against Brain Cancer.
Gliomas - seen as the most common and rapidly growing tumors in the brain - are going to be helped thanks to this drug. In particular, the drug will be able to target the mutation referred to simply as IDH1. For those of you who are unfamiliar with what exactly this entails, it is an alteration that is seen in 70 to 80 percent of all lower-grade tumors in patient. This mutation will make it impossible for the body to utilize protein for the sake of transitioning glucose into energy.
The study went on for a period of 14 weeks and the impact of 5-azacytidine had proven itself to be, to say the least, beneficial. Tumor growth in mice went down tremendously and a relapse did not occur since that point. It didn't even stop seven weeks after the use of the drug in question had been stopped. I do not think that you need me to tell you that this is extremely beneficial for those who have seen difficulties in terms of therapies and tumor regression.
Researchers typically do not expect to see tumor regression, which speaks volumes about how strong this study was in the realm of brain tumor research. These findings could prove useful in the future if the mice utilized have seen positive results. Is it possible that humans will be able to benefit from such processes in the long term as well? I like to think that this will be the case but it is just a matter of time as potential work will be gone about.
About the Author:
Contact Voices Against Brain Cancer if you're seeking more information about brain cancer research.
No comments:
Post a Comment